SG10201503080XA - Eif4e binding peptides - Google Patents

Eif4e binding peptides

Info

Publication number
SG10201503080XA
SG10201503080XA SG10201503080XA SG10201503080XA SG10201503080XA SG 10201503080X A SG10201503080X A SG 10201503080XA SG 10201503080X A SG10201503080X A SG 10201503080XA SG 10201503080X A SG10201503080X A SG 10201503080XA SG 10201503080X A SG10201503080X A SG 10201503080XA
Authority
SG
Singapore
Prior art keywords
binding peptides
eif4e binding
eif4e
peptides
binding
Prior art date
Application number
SG10201503080XA
Inventor
Christopher John Brown
Cheng San Brian Chia
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG10201503080XA publication Critical patent/SG10201503080XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG10201503080XA 2010-04-27 2011-04-27 Eif4e binding peptides SG10201503080XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32843710P 2010-04-27 2010-04-27

Publications (1)

Publication Number Publication Date
SG10201503080XA true SG10201503080XA (en) 2015-06-29

Family

ID=44861796

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201503080XA SG10201503080XA (en) 2010-04-27 2011-04-27 Eif4e binding peptides
SG2012076261A SG184860A1 (en) 2010-04-27 2011-04-27 Eif4e binding peptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012076261A SG184860A1 (en) 2010-04-27 2011-04-27 Eif4e binding peptides

Country Status (4)

Country Link
US (2) US9018348B2 (en)
EP (1) EP2569327B1 (en)
SG (2) SG10201503080XA (en)
WO (1) WO2011136744A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104411715A (en) * 2012-07-09 2015-03-11 霍夫曼-拉罗奇有限公司 Cell penetrating peptides to target eif4e
CN105263950A (en) * 2013-03-21 2016-01-20 新加坡科技研究局 Stapling eif4e interacting peptides
EP3947416A4 (en) * 2019-03-29 2023-05-31 Agency for Science, Technology and Research Peptides and compounds that bind to elongation initiation factor 4e
TW202114681A (en) 2019-07-02 2021-04-16 美商ｅＦＦＥＣＴＯＲ醫療公司 Translation inhibitors and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135370T1 (en) 1988-12-22 1996-03-15 Kirin Amgen Inc CHEMICALLY MODIFIED GRANULOCYTE COLONY EXCITING FACTOR
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
WO1995000162A1 (en) 1993-06-21 1995-01-05 Enzon, Inc. Site specific synthesis of conjugated peptides
US5880131A (en) 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5965566A (en) 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US6380161B1 (en) * 1999-06-21 2002-04-30 Inkine Pharmaceutical Company, Inc. Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions
GB9914480D0 (en) * 1999-06-21 1999-08-18 Univ Dundee Use of peptides
WO2003057235A2 (en) 2002-01-10 2003-07-17 Imperial College Innovations Ltd Modification of feeding behavior
SG159387A1 (en) 2002-11-26 2010-03-30 Biocon Ltd In Modified natriuretic compounds, conjugates, and uses thereof
EP1668130A2 (en) * 2003-09-18 2006-06-14 Isis Pharmaceuticals, Inc. Modulation of eif4e expression

Also Published As

Publication number Publication date
US9533023B2 (en) 2017-01-03
EP2569327A4 (en) 2013-12-18
EP2569327A1 (en) 2013-03-20
EP2569327B1 (en) 2016-05-25
US20130130989A1 (en) 2013-05-23
US20160038567A1 (en) 2016-02-11
US9018348B2 (en) 2015-04-28
SG184860A1 (en) 2012-11-29
WO2011136744A1 (en) 2011-11-03

Similar Documents

Publication Publication Date Title
HRP20191852T8 (en) Polypeptides
IL222323A0 (en) Tnf - alpha binding proteins
HK1182719A1 (en) Polypeptides
IL222980A0 (en) Il-1 binding proteins
ZA201300975B (en) Binding proteins for hepcidin
EP2588129A4 (en) Small-molecule-targeted protein degradation
ZA201205624B (en) Cd127 binding proteins
GB201012651D0 (en) Peptides
EP2550578A4 (en) Associated file
IL226157A0 (en) Antigen binding proteins
EP2569338A4 (en) Binding systems
GB201016494D0 (en) Polypeptide
GB201018480D0 (en) Factors
EP2627674A4 (en) Egfr-based peptides
EP2576597A4 (en) Rhamm binding peptides
SG10201503080XA (en) Eif4e binding peptides
EP2793918A4 (en) Hdc-sign binding peptides
GB201005962D0 (en) Case folder
GB201003906D0 (en) Binding polypeptides
GB201103961D0 (en) Binding polypeptides
TWM400980U (en) Binding
GB201013489D0 (en) Binding surfaces
AU2010057V (en) Fernside Glycine max
GB201010143D0 (en) Comb binding
TWM389093U (en) Binding device